EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE
Clinical trials for EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE explained in plain language.
Never miss a new study
Get alerted when new EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE trials appear
Sign up with your email to follow new studies for EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new drug targets rare lymphoma in early trial
Disease control Recruiting nowThis study tests an investigational drug called epcoritamab in 25 adults newly diagnosed with marginal zone lymphoma, a slow-growing blood cancer. The goal is to see if the drug can shrink or eliminate tumors. Participants will receive the drug for several cycles, and doctors wil…
Matched conditions: EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE
Phase: PHASE2 • Sponsor: Izidore Lossos, MD • Aim: Disease control
Last updated May 26, 2026 10:55 UTC
-
Engineered immune cells take aim at Hard-to-Treat lymphomas
Disease control Recruiting nowThis study tests a new treatment for people with certain types of lymphoma or leukemia that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells (T cells) that are modified in a lab to recognize and attack cancer cells. The main g…
Matched conditions: EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 10:50 UTC